Drug Discovery

Five ways machine learning can power life science data analysis

Intellegens announces Alchemite™ Academic Programme

Focus Group shares new case studies and examples

Press Release: Alchemite™ 2022 Autumn Release

Knowledge from noise – new algorithm turns uncertainty into a positive

Didn’t we do this already? More value from R&D knowledge

Predicting pharmacokinetics with Optibrium and AstraZeneca

Alchemite™ powered deep learning with “small data”

Alchemite™ identifies potential antimalarial drug

Alchemite™ validated for global pharma data in peer-reviewed study

Optimising kinase profiling programs with Optibrium and Genentech

Innovate UK Funded Project Produces Next-Generation AI Drug Discovery Platform

2 / 32

Search